Arena International is delighted to announce the launch of the 1^st Annual Preclinical Development Operations Summit for November 2016. We will be joined on November 15-16 in Boston by senior representatives with job roles surrounding preclinical research, preclinical development, in-vivo pharmacology, toxicology, preclinical safety and procurement. 

This exciting event will explore key challenges of preclinical development from Lead to IND, covering topics such as vendor management and selection, preclinical data requirements, funding and IND drafting and submission. 

Key speakers include:

• Tom Parry, Sr. Director, Pharmacology and Safety, Acorda Therapeutics
• Leslie Sloan, President, Ipsen
• Angelos Dovletoglou, Sr. Director Toxicology, Epizyme
• Eric Austin, Global Early Development Lead, EMD Serono
• Allen Pierce, Director of Safety and Toxicology, Radius Health
• Lawrence J. Thomas, Sr. Director, Preclinical Research and Development, Celldex Therapeutics 

View the full speaker line up here 

Key sessions include: 

• Opening Keynote: Case study: Exploring the operational challenges from Lead to IND 
  - Leslie Sloan, President, Ipsen
• Discussing best practices for finding reliable service providers to ensure preclinical development studies are carried out to a quality standard for emerging companies 
  - Frank Leu, CEO, Novapeutics
• Determining how to effectively communicate with your CRO to ensure a truly collaborative relationship
  - Aidan Curran, Sr. Director Research, Pulmatrix

View the program highlights or the full program 

Join us this November to improve efficiency and form new working relationships through ample networking opportunities. 

View the website here: http://www.arena-international.com/preclinical/ 

There are FREE places available for senior representatives – Don’t miss out! 

Book with the code MK-SCB today!